4351 - 4400 of 8112 Results
Title
Year
- Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease2020OPENTitle: Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 140Issue #: 3Start Page: 341End Page: 358Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-020-02181-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-020-02181-3.pdfCitation Count: 92
- Monoamine oxidase A inhibition as monotherapy reverses parkinsonism in the MPTP-lesioned marmoset2020RESTRICTEDTitle: Monoamine oxidase A inhibition as monotherapy reverses parkinsonism in the MPTP-lesioned marmosetJournal Name: Naunyn-Schmiedeberg's Archives of PharmacologyPublisher: Springer Science and Business Media LLCVol: 393Issue #: 11Start Page: 2139End Page: 2144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00210-020-01927-wCitation Count: 3
- Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional study2020OPENTitle: Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi‐institutional studyJournal Name: Cancer MedicinePublisher: WileyVol: 9Issue #: 16Start Page: 5798End Page: 5806Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/cam4.3255Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.3255Citation Count: 60
- Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis2020RESTRICTEDTitle: Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 100End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.026Citation Count: 29
- Single-vesicle imaging quantifies calcium’s regulation of nanoscale vesicle clustering mediated by α-synuclein2020OPENTitle: Single-vesicle imaging quantifies calcium’s regulation of nanoscale vesicle clustering mediated by α-synucleinJournal Name: Microsystems & NanoengineeringPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41378-020-0147-1Best OA location URL: https://www.nature.com/articles/s41378-020-0147-1.pdfCitation Count: 9
- Deep Brain Stimulation Impact on Social and Occupational Functioning in Parkinson's Disease with Early Motor Complications2020OPENTitle: Deep Brain Stimulation Impact on Social and Occupational Functioning in Parkinson's Disease with Early Motor ComplicationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 672End Page: 680Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13015Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13015Citation Count: 7
-
OPENTitle: GBA variants in REM sleep behavior disorderJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1212/wnl.0000000000010042Best OA location URL: https://n.neurology.org/content/neurology/95/8/e1008.full.pdfCitation Count: 61
- Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice2020OPENTitle: Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic MiceJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 21Issue #:Start Page: 623End Page: 635Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.omtn.2020.06.027Best OA location URL: http://www.cell.com/article/S2162253120301888/pdfCitation Count: 37
-
OPENTitle: Genetic Analysis of RAB39B in an Early-Onset Parkinson's Disease CohortJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00523Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00523/pdfCitation Count: 13
- Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD)2020OPENTitle: Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD)Journal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 4Start Page: 1561End Page: 1569Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202090Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683040Citation Count: 6
-
OPENTitle: Deep brain stimulation lead removal in Tourette syndromeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 89End Page: 93Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.025Best OA location URL: https://cris.maastrichtuniversity.nl/files/76215147/Leentjens_2020_Deep_brain_stimulation_lead_removal.pdfCitation Count: 8
- Dynamical system based compact deep hybrid network for classification of Parkinson disease related EEG signals2020RESTRICTEDTitle: Dynamical system based compact deep hybrid network for classification of Parkinson disease related EEG signalsJournal Name: Neural NetworksPublisher: Elsevier BVVol: 130Issue #:Start Page: 75End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neunet.2020.06.018Citation Count: 69
-
OPENTitle: Implementation and Patient Experience of Outpatient TeleneurologyJournal Name: Telemedicine and e-HealthPublisher: Mary Ann Liebert IncVol: 27Issue #: 3Start Page: 323End Page: 329Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1089/tmj.2020.0032Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958989Citation Count: 29
- Phenomenology and Outcomes of In‐Patients With Parkinson's Disease During the Coronavirus Disease 2019 Pandemic2020OPENTitle: Phenomenology and Outcomes of In‐Patients With Parkinson's Disease During the Coronavirus Disease 2019 PandemicJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1295End Page: 1296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28205Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28205Citation Count: 24
-
OPENTitle: Secondary Worsening Following DYT1 Dystonia Deep Brain Stimulation: A Multi-country CohortJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.00242Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2020.00242/pdfCitation Count: 13
- DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study2020RESTRICTEDTitle: DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 36End Page: 42Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.019Citation Count: 8
- Evaluation of an Interdisciplinary Screening Program for People With Parkinson Disease and Movement Disorders2020OPENTitle: Evaluation of an Interdisciplinary Screening Program for People With Parkinson Disease and Movement DisordersJournal Name: Archives of Rehabilitation Research and Clinical TranslationPublisher: Elsevier BVVol: 2Issue #: 3Start Page: 100067End Page: 100067Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.arrct.2020.100067Best OA location URL: https://doi.org/10.1016/j.arrct.2020.100067Citation Count: 3
-
RESTRICTEDTitle: Parkinson’s disease: etiopathogenesis and treatmentJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 8Start Page: 795End Page: 808Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2019-322338Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/8/795.full.pdfCitation Count: 478
-
RESTRICTEDTitle: Parkinson's Disease, NOTCH3 Genetic Variants, and White Matter HyperintensitiesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2090End Page: 2095Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28171Citation Count: 23
- The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates2020OPENTitle: The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein AggregatesJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 57Issue #: 9Start Page: 3803End Page: 3813Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12035-020-01988-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415709Citation Count: 60
-
OPENTitle: GBA variation and susceptibility to multiple system atrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 64End Page: 69Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.007Best OA location URL: http://manuscript.elsevier.com/S1353802020301723/pdf/S1353802020301723.pdfCitation Count: 20
- Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers2020OPENTitle: Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 57End Page: 63Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.033Best OA location URL: http://www.prd-journal.com/article/S1353802020301504/pdfCitation Count: 21
-
OPENTitle: Partial Correlation Coefficient for a Study With Repeated MeasurementsJournal Name: Statistics in Biopharmaceutical ResearchPublisher: Informa UK LimitedVol: 13Issue #: 4Start Page: 448End Page: 454Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/19466315.2020.1784780Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735669Citation Count: 8
-
OPENTitle: A Novel Phenotype Associated with CaSR‐Related Familial Brain CalcificationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 701End Page: 703Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13009Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13009Citation Count: 5
- Clinical and imaging features of newly recognized Kelch-like protein 11 paraneoplastic syndrome2020OPENTitle: Clinical and imaging features of newly recognized Kelch-like protein 11 paraneoplastic syndromeJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 3Start Page: 134End Page: 135Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000009895Best OA location URL: https://n.neurology.org/content/neurology/95/3/134.full.pdfCitation Count: 6
- A computational model‐based analysis of basal ganglia pathway changes in Parkinson’s disease inferred from resting‐state fMRI2020OPENTitle: A computational model‐based analysis of basal ganglia pathway changes in Parkinson’s disease inferred from resting‐state fMRIJournal Name: European Journal of NeurosciencePublisher: WileyVol: 53Issue #: 7Start Page: 2278End Page: 2295Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ejn.14868Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.14868Citation Count: 24
- A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson’s Disease: Study Protocol and Design2020OPENTitle: A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson’s Disease: Study Protocol and DesignJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1195End Page: 1207Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202019Best OA location URL: https://escholarship.org/content/qt9nz468vj/qt9nz468vj.pdf?t=qqcy3nCitation Count: 10
- Carbidopa and Levodopa Extended Release Capsules in Patients with and without Troublesome and Non-Troublesome Dyskinesia2020OPENTitle: Carbidopa and Levodopa Extended Release Capsules in Patients with and without Troublesome and Non-Troublesome DyskinesiaJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 915End Page: 925Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202010Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202010?id=journal-of-parkinsons-disease%2Fjpd202010Citation Count: 2
-
RESTRICTEDTitle: Effects of self-administered cannabidiol in a patient with multiple system atrophyJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 4Start Page: 355End Page: 356Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10286-020-00704-2Citation Count: 7
- GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation Learning2020OPENTitle: GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation LearningJournal Name: IEEE/ACM Transactions on Computational Biology and BioinformaticsPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 19Issue #: 1Start Page: 491End Page: 500Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/tcbb.2020.3003830Best OA location URL: https://ieeexplore.ieee.org/ielx7/8857/9702518/09121705.pdfCitation Count: 8
-
OPENTitle: Happiness: A Novel Outcome in Parkinson Studies?Journal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1261End Page: 1266Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-201999Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd201999?id=journal-of-parkinsons-disease%2Fjpd201999Citation Count: 14
-
OPENTitle: Parkinson's Disease Research on the African Continent: Obstacles and OpportunitiesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00512Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00512/pdfCitation Count: 23
-
OPENTitle: Timing Is Everything: The T‐Cell Response to α‐Synuclein Is Maximal in Early Parkinson'sJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 7Start Page: 1137End Page: 1137Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28122Best OA location URL: https://www.repository.cam.ac.uk/bitstream/1810/305371/1/Lindestam%20Arlehamn_Nature%20Comms%20Hot%20Topic_FINAL_6.5.20.pdfCitation Count: 6
- Translation, Validation, Diagnostic Accuracy, and Reliability of Screening Questionnaire for Parkinsonism in Three African Countries2020RESTRICTEDTitle: Translation, Validation, Diagnostic Accuracy, and Reliability of Screening Questionnaire for Parkinsonism in Three African CountriesJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1113End Page: 1122Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-202040Citation Count: 4
-
OPENTitle: Understanding the Lexicon of Fatigue in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1185End Page: 1193Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-202029Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202029?id=journal-of-parkinsons-disease%2Fjpd202029Citation Count: 9
- A novel method for calculating beta band burst durations in Parkinson’s disease using a physiological baseline2020OPENTitle: A novel method for calculating beta band burst durations in Parkinson’s disease using a physiological baselineJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 343Issue #:Start Page: 108811End Page: 108811Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jneumeth.2020.108811Best OA location URL: https://doi.org/10.1016/j.jneumeth.2020.108811Citation Count: 30
- Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies2020OPENTitle: Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body SynucleinopathiesJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 3Start Page: 503End Page: 512Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25824Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719613Citation Count: 101
- Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset2020OPENTitle: Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease OnsetJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1346End Page: 1356Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28144Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28144Citation Count: 30
- Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease Research2020OPENTitle: Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease ResearchJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00524Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00524/pdfCitation Count: 35
- Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach2020OPENTitle: Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approachJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00388-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00388-2Citation Count: 59
- Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrum2020RESTRICTEDTitle: Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrumJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 97Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.06.007Citation Count: 50
- Enhancing convolution-based sentiment extractor via dubbed N-gram embedding-related drug vocabulary2020RESTRICTEDTitle: Enhancing convolution-based sentiment extractor via dubbed N-gram embedding-related drug vocabularyJournal Name: Network Modeling Analysis in Health Informatics and BioinformaticsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13721-020-00248-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13721-020-00248-5.pdfCitation Count: 9
-
RESTRICTEDTitle: Getting ahead in the race for a cure: How nonprofits are financing biomedical R&DJournal Name: Research PolicyPublisher: Elsevier BVVol: 49Issue #: 8Start Page: 104032End Page: 104032Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.respol.2020.104032Citation Count: 3
- Identifying and predicting Parkinson’s disease subtypes through trajectory clustering via bipartite networks2020OPENTitle: Identifying and predicting Parkinson’s disease subtypes through trajectory clustering via bipartite networksJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 15Issue #: 6Start Page: e0233296End Page: e0233296Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0233296Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0233296&type=printableCitation Count: 25
-
RESTRICTEDTitle: LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00577Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00577/pdfCitation Count: 51
- Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial2020RESTRICTEDTitle: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 7Start Page: 591End Page: 600Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30136-8Citation Count: 104
-
OPENTitle: Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 3Start Page: 574End Page: 587Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25811Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25811Citation Count: 70
-
OPENTitle: Genetic variants and functional pathways associated with resilience to Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 8Start Page: 2561End Page: 2575Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awaa209Best OA location URL: https://academic.oup.com/brain/article-pdf/143/8/2561/37356057/awaa209.pdfCitation Count: 112
-
RESTRICTEDTitle: LRRK2 Phosphorylation, More Than an EpiphenomenonJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00527Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00527/pdfCitation Count: 41
-
RESTRICTEDTitle: The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 10Issue #: 6Start Page: 912End Page: 912Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom10060912Best OA location URL: https://www.mdpi.com/2218-273X/10/6/912/pdf?version=1593094633Citation Count: 21